☆ 4.4 Editorial Material

Interleukin 4 or Cytokine Antagonists? Time to Change the Search for Novel Psoriasis Therapies

DERMATOLOGY (2010)

Journal

DERMATOLOGY

Volume 221, Issue 1, Pages 27-29

Publisher

KARGER

DOI: 10.1159/000314153

Keywords

-

Categories

Dermatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Immunology

Perspective: Daniela Novick, cytokines and their receptors

Pietro Ghezzi, Giamila Fantuzzi, Charles A. A. Dinarello

Summary: This Perspective highlights the work of Dr. Daniela Novick on cytokine biology, specifically her identification of soluble receptors and binding proteins for various cytokines using affinity chromatography. Her findings have been crucial in the development of monoclonal antibodies against interferons and cytokines. The Perspective also discusses her recent review on this topic.

FRONTIERS IN IMMUNOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer

Jingwei Shi, Xujun Song, Benno Traub, Michael Luxenhofer, Marko Kornmann

Summary: IL-4 and IL-13 are pleiotropic Th2 cytokines involved in immune responses and have been found to play a role in oncogenesis and tumor progression. Their effects on tumor cells are mediated through specific receptors, with IL-4R alpha/IL-13R alpha 1 being the main target in tumors. Understanding the implications of these cytokines and their receptors in pancreatic cancer helps in developing potential new diagnostic and therapeutic strategies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Medicine, Research & Experimental

Drug-induced liver injury and prospect of cytokine based therapy; A focus on IL-2 based therapies

Narendra Kumar, Salim Surani, George Udeani, Sara Mathew, Sharon John, Soniya Sajan, Jayshree Mishra

Summary: Drug-induced liver injury (DILI) is a common cause of liver failure and transplant, with factors such as age, ethnicity, gender, liver diseases, renal function, pregnancy, alcohol consumption, and drug interactions affecting its severity. Characteristics of DILI-associated inflammation include hepatocyte apoptosis and necrosis, with therapeutic approaches depending on the type of inflammation. Treatment may involve discontinuing the causative medication, vaccination, and dietary supplements.

LIFE SCIENCES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds

Huilin Yang, Umut Y. Ulge, Alfredo Quijano-Rubio, Zachary J. Bernstein, David R. Maestas, Jung-Ho Chun, Wentao Wang, Jian-Xin Lin, Kevin M. Jude, Srujan Singh, Brian T. Orcutt-Jahns, Peng Li, Jody Mou, Liam Chung, Yun-Huai Kuo, Yasmin H. Ali, Aaron S. Meyer, Warren L. Grayson, Nicola M. Heller, K. Christopher Garcia, Warren J. Leonard, Daniel-Adriano Silva, Jennifer H. Elisseeff, David Baker, Jamie B. Spangler

Summary: In this study, IL-4 cytokine mimetics called Neo-4 were designed based on a de novo engineered IL-2 mimetic scaffold. These cytokines can mimic the physiological functions of IL-4 and offer insights into differential IL-4 signaling through type I versus type II receptors. The design workflow of this study can inform the development of targeted cytokine therapeutics.

NATURE CHEMICAL BIOLOGY (2023)

Add to Collection

Review Dermatology

Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies

Mitchell S. Davis, Riley K. Spencer, Chandler E. Johnson, Kareem G. Elhage, Joy Q. Jin, Marwa Hakimi, Tina Bhutani, Wilson Liao

Summary: The risk of developing CTCL in patients using psoriasis biologics appears to be rare, with the highest number of reported cases associated with TNF inhibitors and no reported cases with IL-23 inhibitors.

DERMATOLOGY AND THERAPY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Epithelium-Derived Cytokines in Atopic Dermatitis and Psoriasis: Evidence and Therapeutic Perspectives

Francesco Borgia, Paolo Custurone, Lucia Peterle, Giovanni Pioggia, Sebastiano Gangemi

Summary: Epithelium-derived cytokines may represent a therapeutic opportunity for patients with atopic dermatitis and psoriasis, especially in itch control. These three cytokines are interconnected in both acute and chronic phases of these diseases, showing potential as target therapies or biomarkers of disease activity.

BIOMOLECULES (2021)

Add to Collection

Article Cell Biology

The glycolysis/HIF-1α axis defines the inflammatory role of IL-4-primed macrophages

Buyun Dang, Qingxiang Gao, Lishan Zhang, Jia Zhang, Hanyi Cai, Yanhui Zhu, Qiumei Zhong, Junqiao Liu, Yujia Niu, Kairui Mao, Nengming Xiao, Wen-Hsien Liu, Shu-hai Lin, Jialiang Huang, Stanley Ching-Cheng Huang, Ping-Chih Ho, Shih-Chin Cheng

Summary: This study demonstrates the important role of IL-4-primed M2 macrophages in inflammation resolution and wound healing. The metabolic divergence between canonical M2 and non-canonical proinflammatory-prone M2INF macrophages occurs after the IL-4Ra/Stat6 axis, and glycolysis supports the proinflammatory phenotype of M2INF macrophages. The findings also suggest that IL-4 induction of M2INF macrophages can confer a survival advantage against bacterial infection in vivo.

CELL REPORTS (2023)

Add to Collection

Article Microbiology

Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?

Leland Shapiro, Sias Scherger, Carlos Franco-Paredes, Amal Gharamti, Andres F. Henao-Martinez

Summary: EMA and FDA have announced conditions for using rhIL-1ra to treat COVID-19 based on positive results from a clinical trial. This article reviews the feasibility of IL-1 blockade as a treatment for COVID-19 and discusses its potential application in sepsis treatment.

FRONTIERS IN MICROBIOLOGY (2023)

Add to Collection

Article Dermatology

Genetic variants in IL-17A rs10484879 and serum levels of IL-17A are associated with psoriasis risk

Burak Aksan, Aysegul Basak Akadam-Teker

Summary: The TT genotype and T allele of IL-17A rs10484879 are associated with an increased risk of psoriasis in the Turkish population. This study suggests that IL-17A polymorphism may play a role in the pathogenesis of the disease. The IL-17A serum levels were also found to be associated with the genotype distribution.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2022)

Add to Collection

Article Allergy

Comprehensive analysis of human IL-4 receptor subunits shows compartmentalization in steady state and dupilumab treatment

Lukas E. M. Heeb, Onur Boyman

Summary: This study characterized IL-4R subunit expression in different human immune cell subsets and found that different subsets contain surface and intracellular IL-4R pools, which are differently affected by targeted biologic treatment.

ALLERGY (2023)

Add to Collection

Review Dermatology

Immunogenicity of biologic therapies in psoriasis: Myths, facts and a suggested approach

T. Tsakok, T. Rispens, P. Spuls, A. Nast, C. Smith, K. Reich

Summary: The article discusses the immunogenicity of biologic drugs in clinical practice, addressing common misconceptions about ADA and proposing a categorization and management approach for commonly used biologics in dermatological conditions like psoriasis. It also emphasizes the need for further research to enhance knowledge in this area.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Expansion of circulating stem-like CD8+ T cells by adding CD122-directed IL-2 complexes to radiation and anti-PD1 therapies in mice

Kateryna Onyshchenko, Ren Luo, Elena Guffart, Simone Gaedicke, Anca-Ligia Grosu, Elke Firat, Gabriele Niedermann

Summary: IL-2 complexes (IL-2c) complexed with anti-IL-2 can enhance T cell function and promote tumor rejection. The combination of radiation therapy (RT) with immune checkpoint blockade and IL-2c increases tumor-specific CD8(+) T cell numbers and effectively reduces tumor size. CD8(+) T cells isolated from blood after the triple treatment can be used for adoptive transfers.

NATURE COMMUNICATIONS (2023)

Add to Collection

Review Medicine, Research & Experimental

Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?

Dea Metko, Tiago Torres, Ronald Vender

Summary: Promising advancements in psoriasis management have emerged in the past two decades, specifically with the development of highly effective targeted biologic therapies. However, classifying these therapies as either immunomodulators or immunosuppressants has been a challenge. This review aims to discuss the distinguishing features of immunomodulators and immunosuppressants to better categorize biologic therapies for psoriasis management and enhance understanding of associated risks among patients and physicians.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time

Eva Klara Merzel Sabovic, Mateja Starbek Zorko, Miodrag Janic

Summary: Psoriasis is a chronic systemic inflammatory disease with a close association with cardiovascular diseases. In addition to treating psoriasis, physicians should also assess and address cardiovascular risk, and be familiar with pharmacologic options that can target psoriasis and reduce cardiovascular risk.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Immunology

Engineering the IL-4/IL-13 axis for targeted immune modulation

Zachary J. J. Bernstein, Anjali Shenoy, Amy Chen, Nicola M. M. Heller, Jamie B. B. Spangler

Summary: IL-4 and IL-13 cytokines play important roles in immune activity, especially in T helper 2 cell-mediated inflammation, immune regulation, antibody production, and fibrosis. Manipulating the IL-4/IL-13 axis through cytokine engineering, fusion protein formulation, antagonist development, cell engineering, and biosensor design can lead to the discovery of new immunotherapies targeting allergy, autoimmune diseases, and cancer.

IMMUNOLOGICAL REVIEWS (2023)

Add to Collection

Article Multidisciplinary Sciences

Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours

Ellen Brenner, Barbara F. Schoerg, Fatima Ahmetlic, Thomas Wieder, Franz Joachim Hilke, Nadine Simon, Christopher Schroeder, German Demidov, Tanja Riedel, Birgit Fehrenbacher, Martin Schaller, Andrea Forschner, Thomas Eigentler, Heike Niessner, Tobias Sinnberg, Katharina S. Boehm, Nadine Hoemberg, Heidi Braumueller, Daniel Dauch, Stefan Zwirner, Lars Zender, Dominik Sonanini, Albert Geishauser, Juergen Bauer, Martin Eichner, Katja J. Jarick, Andreas Beilhack, Saskia Biskup, Dennis Doecker, Dirk Schadendorf, Leticia Quintanilla-Martinez, Bernd J. Pichler, Manfred Kneilling, Ralph Mocikat, Martin Roecken

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Pathology

Expression of DNA Methyltransferase 1 Is a Hallmark of Melanoma, Correlating with Proliferation and Response to B-Raf and Mitogen-Activated Protein Kinase Inhibition in Melanocytic Tumors

Maximilian Gassenmaier, Maximilian Rentschler, Birgit Fehrenbacher, Thomas K. Eigentler, Kristian Ikenberg, Corinna Kosnopfel, Tobias Sinnberg, Heike Niessner, Hans Boesmueller, Nikolaus B. Wagner, Martin Schaller, Claus Garbe, Martin Roecken

AMERICAN JOURNAL OF PATHOLOGY (2020)

Add to Collection

Article Oncology

Distinct Mutation Patterns Reveal Melanoma Subtypes and Influence Immunotherapy Response in Advanced Melanoma Patients

Franz J. Hilke, Tobias Sinnberg, Axel Gschwind, Heike Niessner, German Demidov, Teresa Amaral, Stephan Ossowski, Irina Bonzheim, Martin Roecken, Olaf Riess, Claus Garbe, Christopher Schroeder, Andrea Forschner

CANCERS (2020)

Add to Collection

Article Oncology

Therapy of lymphoma by immune checkpoint inhibitors: the role of T cells, NK cells and cytokine-induced tumor senescence

Fatima Ahmetlic, Josia Fauser, Tanja Riedel, Vera Bauer, Carolin Flessner, Nadine Hoemberg, Roman Hennel, Ellen Brenner, Kirsten Lauber, Martin Roecken, Ralph Mocikat

Summary: The study found that in treating lymphoma in mice with immune checkpoint inhibitors, 20% to 30% of mice were long-term protected and did not show clinical signs of tumor growth. The therapeutic effect depended on cytokine-induced senescence in malignant B cells. Therapy with immune checkpoint antibodies improved T cell functions and long-time survivors were only observed in the presence of T cells.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Oncology

Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma

Andrea Forschner, Tobias Sinnberg, Gabi Mroz, Christopher Schroeder, Christian Philipp Reinert, Sergios Gatidis, Michael Bitzer, Thomas Eigentler, Claus Garbe, Heike Niessner, Martin Rocken, Cristiana Roggia, Sorin Armeanu-Ebinger, Olaf Riess, Sven Mattern, Dominik Nann, Irina Bonzheim

Summary: Limited treatment options exist for metastatic NRAS mutant melanoma patients resistant to immune checkpoint inhibitors. Molecular defects in cell cycle regulation can be additional challenges for these patients. Individualized therapy based on next-generation sequencing results can be effective, and further collaborative research is needed to expand treatment options for NRAS mutated melanoma.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection

Article Oncology

Interleukin-10 counteracts T-helper type 1 responses in B-cell lymphoma and is a target for tumor immunotherapy

Yanchun Ma, Vera Bauer, Tanja Riedel, Fatima Ahmetlic, Nadine Homberg, Thomas P. Hofer, Martin Rocken, Ralph Mocikat

Summary: The study reveals that IL-10 suppresses ongoing immune responses in lymphoma and may be a potential target for immunotherapy.

CANCER LETTERS (2021)

Add to Collection

Article Ophthalmology

Mesalazine Suppresses Proinflammatory Cytokines in Patients with Acute Anterior Uveitis Independently of HLA-B27

Nikola Smatlik, Nourhan Mortada, Martin Roecken, Amir S. Yazdi, Manfred Zierhut

Summary: The study revealed the inhibitory effect of 5-ASA on proinflammatory cytokines in PBMCs of patients with HLA-B27+ and HLA-B27- acute anterior uveitis. The results showed similarities between the two types of AAU but did not explain how HLA-B27 status affects the therapeutic response to 5-ASA.

OCULAR IMMUNOLOGY AND INFLAMMATION (2022)

Add to Collection

Article Oncology

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study

Nikolaus B. Wagner, Max M. Lenders, Kathrin Kuehl, Lydia Reinhardt, Fiona Andre, Milena Dudda, Natalie Ring, Chiara Ebel, Ramon Staeger, Caroline Zellweger, Roland Lang, Michael Paar, Philipp Gussek, Georg Richtig, Suzan H. Stuermer, Susanne Kimeswenger, Angela Oellinger, Andrea Forschner, Ulrike Leiter, Benjamin Weide, Maximilian Gassenmaier, Amadeus Schraag, Bernhard Klumpp, Wolfram Hoetzenecker, Carola Berking, Erika Richtig, Mirjana Ziemer, Johanna Mangana, Patrick Terheyden, Carmen Loquai, Van Anh Nguyen, Christoffer Gebhardt, Friedegund Meier, Stefan Diem, Antonio Cozzio, Lukas Flatz, Martin Roecken, Claus Garbe, Thomas K. Eigentler

Summary: Checkpoint inhibitors have greatly improved the treatment of metastatic melanoma patients. This study developed a novel method to estimate pretreatment metastatic growth rate (MGR) and found that high MGR is strongly associated with unfavorable survival outcomes in melanoma patients receiving anti-PD-1 antibodies.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Add to Collection

Article Oncology

Immune checkpoint blockade impairs immunosuppressive mechanisms of regulatory T cells in B-cell lymphoma

Vera Bauer, Fatima Ahmetlic, Nadine Hoemberg, Albert Geishauser, Martin Roecken, Ralph Mocikat

Summary: Research has shown that in malignant diseases, Tregs mediate immunosuppression through direct contact and IL-10. ICB antibodies may reduce Tregs' suppressive capacity by altering the inflammatory environment, contributing to the interference with Treg-dependent immunosuppression.

TRANSLATIONAL ONCOLOGY (2021)

Add to Collection

Article Cell Biology

ASC Speck Formation after Inflammasome Activation in Primary Human Keratinocytes

Nikola Smatlik, Stefan Karl Drexler, Marc Burian, Martin Roecken, Amir Sadegh Yazdi

Summary: Chronic UV irradiation leads to various skin changes, including inflammation and alterations in pigmentation. UVB exposure induces increased NF-kappa B activation and the induction of inflammatory cytokines, playing a significant role in cell death and inflammation.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

Add to Collection

Article Medicine, Research & Experimental

Low-dose total body irradiation facilitates antitumoral Th1 immune responses

Dominik Sonanini, Christoph M. Griessinger, Barbara F. Schoerg, Philipp Knopf, Klaus Dittmann, Martin Roecken, Bernd J. Pichler, Manfred Kneilling

Summary: The study demonstrated that low-dose TBI can significantly improve the efficacy of CD4+ T cell-based immunotherapies, leading to increased survival of RIP1-Tag2 mice and enhanced infiltration of CD4+ T cells in tumor tissue. This approach may provide a rationale for combining TBI with immunotherapy for cancer treatment in clinical settings.

THERANOSTICS (2021)

Add to Collection

Article Medicine, Research & Experimental

Immunomodulatory role of reactive oxygen species and nitrogen species during T cell-driven neutrophil-enriched acute and chronic cutaneous delayed-type hypersensitivity reactions

Roman Mehling, Johannes Schwenck, Christina Lemberg, Christoph Trautwein, Laimdota Zizmare, Daniela Kramer, Anne Mueller, Birgit Fehrenbacher, Irene Gonzalez-Menendez, Leticia Quintanilla-Martinez, Katrin Schroeder, Ralph P. Brandes, Martin Schaller, Wolfram Ruf, Martin Eichner, Kamran Ghoreschi, Martin Roecken, Bernd J. Pichler, Manfred Kneilling

Summary: ROS/RNS play a dominant role in acute and chronic delayed-type hypersensitivity reactions, with MPO and NOX2 identified as the main sources. However, depletion of only one primary source has marginal and conflicting effects on the outcomes of acute and chronic diseases, demonstrating that ROS/RNS are not a singular entity with different properties at various disease stages.

THERANOSTICS (2021)

Add to Collection

Article Oncology

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

Johanna Winter, Max M. Lenders, Maximilian Gassenmaier, Andrea Forschner, Ulrike Leiter, Benjamin Weide, Mette-Triin Purde, Lukas Flatz, Antonio Cozzio, Martin Rocken, Claus Garbe, Thomas K. Eigentler, Nikolaus B. Wagner

Summary: The study found that the frequency of hepatic immune-related adverse events is underestimated, and the addition of gamma-glutamyl transferase (GGT) to laboratory testing can help detect hepatobiliary toxicity in patients receiving immune checkpoint inhibitors. Immune-related GGT elevations are associated with treatment response and survival outcomes.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Add to Collection

Article Oncology

The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors

Anne Scheuerpflug, Fatima Ahmetlic, Vera Bauer, Tanja Riedel, Martin Roecken, Ralph Mocikat

Summary: The study demonstrates that immune checkpoint blocking therapy may involve dendritic cells in mediating anti-tumor responses through enhancing Th1-type immune response, in addition to directly activating T cells.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Add to Collection

Article Medicine, Research & Experimental

Cancer immunotherapy is accompanied by distinct metabolic patterns in primary and secondary lymphoid organs observed by non-invasive in vivo 18F-FDG-PET

Johannes Schwenck, Barbara Schoerg, Francesco Fiz, Dominik Sonanini, Andrea Forschner, Thomas Eigentler, Benjamin Weide, Manuela Martella, Irene Gonzalez-Menendez, Cristina Campi, Gianmario Sambuceti, Ferdinand Seith, Leticia Quintanilla-Martinez, Claus Garbe, Christina Pfannenberg, Martin Roecken, Christian la Fougere, Bernd J. Pichler, Manfred Kneilling

THERANOSTICS (2020)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.